Hope for a rare cancer: trial tests two new pill options
NCT ID NCT01391962
Summary
This study tested two oral drugs, sunitinib and cediranib, to see if they could control a rare and aggressive cancer called metastatic alveolar soft part sarcoma (ASPS). The trial involved 34 patients whose cancer had spread and was getting worse, and who had not tried this type of drug before. Patients started on one drug and could switch to the other if their cancer progressed, to see which treatment worked better at shrinking tumors and delaying cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA, ALVEOLAR SOFT PART are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.